The World Health Organization (WHO) has released its updated fourth WHO Model List of Essential Medicines for Children (EMLc), which now includes three treatments developed by the Drugs for Neglected Diseases initiative (DNDi) and its partners.
One treatment was also added to the 18th WHO Model List of Essential Medicines (EML) for adults.
The inclusions of the new paediatric therapeutic options to the WHO EMLc attest to the urgent, specific treatment needs of children threatened by neglected diseases such as African sleeping sickness and Chagas disease, and highlight the leading public-goods product-development work of DNDi in the area of paediatric research and development (R&D) for neglected diseases and patients.
Read more at Drugs for Neglected Diseases Initiative